Linkage of a de-identified United States rheumatoid arthritis registry with administrative data to facilitate comparative effectiveness research
- PMID: 24905637
- PMCID: PMC4245366
- DOI: 10.1002/acr.22377
Linkage of a de-identified United States rheumatoid arthritis registry with administrative data to facilitate comparative effectiveness research
Abstract
Objective: Linkages between registries and administrative data may provide a valuable resource for comparative effectiveness research. However, personal identifiers that uniquely identify individuals are not always available. Here we describe methods to link a de-identified arthritis registry and US Medicare data. The linked data set was also used to evaluate the generalizability of the registry to the US Medicare population.
Methods: Rheumatoid arthritis (RA) patients participating in the Consortium of Rheumatology Researchers of North America (CORRONA) registry were linked to Medicare data restricted to rheumatology claims or claims for RA. Deterministic linkage was performed using age, sex, provider identification number, and geographic location of the CORRONA site. We then searched for visit dates in Medicare matching visit dates in CORRONA, requiring ≥1 exact matching date. Linkage accuracy was quantified as a positive predictive value in a subcohort (n = 1,581) with more precise identifiers.
Results: CORRONA participants with self-reported Medicare (n = 11,001) were initially matched to 30,943 Medicare beneficiaries treated by CORRONA physicians. A total of 8,431 CORRONA participants matched on ≥1 visit; 5,317 matched uniquely on all visits. The number of patients who linked and linkage accuracy (from the subcohort) were high for patients with >2 visits (n = 3,458, 98% accuracy), exactly 2 visits (n = 822, 96% accuracy), and 1 visit (n = 1,037, 79% accuracy) that matched exactly on calendar date. Demographics and comorbidity profiles of registry participants were similar to nonparticipants, except participants were more likely to take disease-modifying antirheumatic drugs and biologic agents.
Conclusion: Linkage between a national, de-identified outpatient arthritis registry and Medicare data on multiple nonunique identifiers appears feasible and valid.
Copyright © 2014 by the American College of Rheumatology.
Figures
Similar articles
-
Use of health plan combined with registry data to predict clinical trial recruitment.Clin Trials. 2014 Feb;11(1):96-101. doi: 10.1177/1740774513512185. Epub 2013 Dec 17. Clin Trials. 2014. PMID: 24346611 Free PMC article.
-
Methodological Challenges When Comparing Demographic and Clinical Characteristics of International Observational Registries.Arthritis Care Res (Hoboken). 2015 Dec;67(12):1637-45. doi: 10.1002/acr.22661. Arthritis Care Res (Hoboken). 2015. PMID: 26201948
-
Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease.Ann Rheum Dis. 2016 Oct;75(10):1797-805. doi: 10.1136/annrheumdis-2015-208698. Epub 2016 Feb 8. Ann Rheum Dis. 2016. PMID: 26857699
-
The Corrona US registry of rheumatic and autoimmune diseases.Clin Exp Rheumatol. 2016 Sep-Oct;34(5 Suppl 101):S96-S99. Epub 2016 Oct 19. Clin Exp Rheumatol. 2016. PMID: 27762197 Review.
-
The CORRONA database.Autoimmun Rev. 2006 Jan;5(1):46-54. doi: 10.1016/j.autrev.2005.07.006. Epub 2005 Aug 30. Autoimmun Rev. 2006. PMID: 16338211 Review.
Cited by
-
Validating claims-based algorithms for a systemic lupus erythematosus diagnosis in Medicare data for informed use of the Lupus Index: a tool for geospatial research.Lupus Sci Med. 2024 Oct 14;11(2):e001329. doi: 10.1136/lupus-2024-001329. Lupus Sci Med. 2024. PMID: 39401954 Free PMC article.
-
Treatment patterns and clinical outcomes in patients with rheumatoid arthritis initiating etanercept, adalimumab, or Janus kinase inhibitor as first-line therapy: results from the real-world CorEvitas RA Registry.Arthritis Res Ther. 2023 Sep 9;25(1):166. doi: 10.1186/s13075-023-03120-9. Arthritis Res Ther. 2023. PMID: 37689684 Free PMC article.
-
A cohort of patients in New York State with an alcohol use disorder and subsequent treatment information - A merging of two administrative data sources.J Biomed Inform. 2023 Aug;144:104443. doi: 10.1016/j.jbi.2023.104443. Epub 2023 Jul 16. J Biomed Inform. 2023. PMID: 37455008 Free PMC article.
-
Accuracy of administrative claims prescription fill data to estimate glucocorticoid use and dose in patients with rheumatoid arthritis.Pharmacoepidemiol Drug Saf. 2023 Nov;32(11):1271-1279. doi: 10.1002/pds.5660. Epub 2023 Jun 30. Pharmacoepidemiol Drug Saf. 2023. PMID: 37345649 Free PMC article.
-
Virtual patient identifier (vPID): Improving patient traceability using anonymized identifiers in Japanese healthcare insurance claims database.Heliyon. 2023 May 12;9(5):e16209. doi: 10.1016/j.heliyon.2023.e16209. eCollection 2023 May. Heliyon. 2023. PMID: 37234615 Free PMC article.
References
-
- Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol. 2005;58(4):323–37. - PubMed
-
- Weiss NS. The new world of data linkages in clinical epidemiology: are we being brave or foolhardy? Epidemiology. 2011;22(3):292–4. - PubMed
-
- Potosky AL, Riley GF, Lubitz JD, Mentnech RM, Kessler LG. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care. 1993;31(8):732–48. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
